Although nasopharyngeal carcinoma (NPC) is a rare neoplasm in most regions of the world (an incidence of \<1 per 10^5^ person-years), particularly high incidences have been observed in southern China, especially in the province of Guangdong (20--50 per 10^5^ person-years) ([@bib21]; [@bib4]). According to statistical data reported by the International Agency for Research on Cancer, 33 101 new cases of NPC were diagnosed in China in 2008, accounting for ∼40% of new cases worldwide ([@bib14]). Most of these cases occurred in persons 40--59 years of age and thus have the potential for enormous social devastation ([@bib25]). Therefore, preventive strategies would have substantial benefit in this region. Development of NPC depends on the interaction between genetic susceptibility and environmental factors (for example, Epstein--Barr virus infection, exposure to carcinogens, dietary factors) ([@bib25]). With the exception of salted fish ([@bib25]), the role of dietary components is poorly understood.

Choline is an essential nutrient widely distributed in animals and plants ([@bib24]). Although choline is endogenously synthesised, a choline-deficient diet leads to deficiency in humans ([@bib42]). Choline is oxidised to betaine, which is linked to folate and serves as a methyl donor in one-carbon metabolism to affect the DNA methylation level *in vivo* ([@bib24]). DNA methylation is postulated to have an important role in carcinogenesis ([@bib24]). Deficiencies in dietary choline and betaine could increase the probability of hypomethylation independent of folate levels ([@bib33]) and predispose an individual to the development of neoplasia.

Recent epidemiological studies have revealed an inverse association between choline and/or betaine intake and several types of cancers such as breast cancer ([@bib37]; [@bib46]), lung cancer ([@bib40]) and oesophageal cancer ([@bib20]). From the results of these studies, it is reasonable to speculate that choline and/or betaine intake affects the risk of NPC. However, to our knowledge, there has been no epidemiological study pertaining to the association between dietary choline and/or betaine intake and the risk of NPC. Therefore, the primary goal of our study was to investigate whether intake of dietary choline and/or betaine has protective effects on the risk of NPC in a Chinese population. We also examined the modification of the effect by some potential risk factors, such as folate intake and alcohol consumption, because these factors might interact with choline to alter methylation levels ([@bib10]).

Participants and methods
========================

Study participants
------------------

Between July 2009 and March 2011, we conducted a 1 : 1 matched case--control study in Guangzhou, Guangdong Province, China. The design of the study was described previously ([@bib29]).

In brief, the subjects of the study were patients with histologically confirmed NPC who were hospitalised at Sun Yat-sen University Cancer Center. Patients were included if they were 30--75 years of age, had been diagnosed with NPC within the prior 3 months and had resided in Guangdong Province for more than 10 years. Patients were excluded if they had a family history of NPC within three generations, their dietary habits had changed significantly within the previous 5 years, they were presently suffering a chronic disease (for example, diabetes, stroke, cataract or poor vision) that might influence their dietary habits or affect their routine activities, or they could not speak Mandarin/Cantonese. In addition, patients who reported implausible values for total energy intake (\<700 or \>4200 kcal per day for males; \<500 or \>3500 kcal per day for females), had insufficient data, or refused to participate, were excluded. Of the 653 eligible patients, 600 (91.9%) were retained for these analyses. Among the NPCs, 570 (95.0%) were classified as undifferentiated (type III), and 558 (93.0%) were VCA-IgA seropositive.

One age- (±3 years), sex- and household type- (urban *vs* rural for the previous 10 years) matched hospital-based control subject was recruited per NPC patient. Control subjects were selected from the Sun Yat-sen University Ophthalmic Center. The same inclusion and exclusion criteria that were applied to the NPC patients were applied to the control subjects, with the exception of a history of NPC. Of the 600 control subjects, 249 (41.3%) suffered ocular fundus disease, 111 (18.5%) suffered glaucoma, 107 (17.8%) suffered ocular trauma and 133 (22.2%) suffered another ocular disease.

The study was approved by the ethics committee of the School of Public Health of Sun Yat-sen University, and written informed consent was obtained from all participants.

Dietary assessment
------------------

Dietary intake information was obtained from all participants by means of a semi-quantitative 78-item food frequency questionnaire (FFQ) ([@bib45]). The reference period for the dietary survey was the year prior diagnosis in NPC patients or to interview in control subjects. For each food item on the FFQ, participants chose from five qualitative responses ranging from never to daily and reported the intake amount. Photographs of food portion sizes were provided to help FFQ-takers estimate the amount of food consumed. Individual food items were then converted to a daily intake value (g per day). Individual nutrient or energy intake was calculated by multiplying the daily intake of each food item by the nutrient content in 100 g, then divided by 100 (obtained from the China food composition table, 2004) ([@bib39]).

Our database for dietary betaine and choline intake has been described in detail elsewhere ([@bib46]). Briefly, the betaine and choline contents of foods were determined on the basis of the composition analysis conducted by [@bib43], [@bib44]). Intakes of betaine and choline subclasses, including choline from glycerophosphocholine, free choline, phosphocholine, phosphatidylcholine and sphingomyelin, were calculated as the sum of the daily intake of each food multiplied by the betaine and choline content in 100 **g**, then divided by 100. Total choline intake was calculated as the sum of intakes of the five subclasses.

The reproducibility and validity of the FFQ were assessed previously with six 3-day energy-adjusted diet records at intervals of 2 months over a 12-month period and two FFQs administered 1 year apart and completed by 61 local female subjects ([@bib45]; [@bib46]). The Pearson\'s correlation coefficients for betaine and total and individual choline intakes ranged from 0.23 to 0.48 in comparing the second FFQ and 18-day dietary records and from 0.44 to 0.67 in comparing the two FFQs (23).

Other covariates
----------------

Intakes of energy and nutrients were determined from the FFQ described above. Information on demographics, socioeconomic factors, occupational and domestic exposure to toxic substances, lifestyle, history of chronic disease(s), use of medications and physical activity over the previous 12 months was obtained by means of a standardised questionnaire. According to labour intensity, occupation were grouped into light occupation (administrative staff, health care staff, teachers, clerks, financial and legal staff, engineering technicians), moderate occupation (businessmen and service personnel, culture and arts personnel, housewives and self-employed persons), or heavy activity occupation (uniformed security personnel, workers, farmers and fishermen). For the exposures to toxic materials or detrimental environment, we interviewed participants if they had never or ever occupational exposure of either one of the following factors over 1 year: heat, organic solvents, pesticides, heavy metals, smoke from burning incense, anti-mosquito coils, new furniture or decoration and radiation. Participants\' height (m) and weight (kg) were measured on digital scales, and body mass index (BMI) (kg m^−2^) was calculated. Questionnaires were administered and measurements were taken by trained interviewers in the same manner for all participants, and each interviewer completed an equal number of NPC patient and control subject interviews.

Statistical analysis
--------------------

Data were analysed using SPSS version 17.0 for WINDOWS (SPSS Inc, Chicago, IL, USA). All *P-*values are two-sided, and statistical significance was considered to be *P*\<0.05.

As no statistically significant interactions were found, all analyses were performed for men and women combined. We used a residual nutrient method (diseases risk=*β*1 nutrient residual+*β*2 total energy) established by [@bib34] to adjust for energy intake for betaine and total choline and its subclasses. We grouped energy-adjusted intakes of betaine and choline and its subclasses into quartiles (Q1--Q4) based on control subjects by sex, and the sex-specific cutoffs were then applied to the NPC patients. The lowest quartile (Q1) served as the reference group. Conditional logistic regression was used to assess the association between energy-adjusted dietary betaine and total and individual choline intakes and the risk of NPC, and the associations were expressed as odds ratios (ORs) with 95% confidence intervals (CIs). In our multivariable model, we adjusted for age (year), BMI (kg m^−2^), occupation (light, moderate or heavy activity), marital status (married, unmarried/divorced/widowed), education level (primary school or below, secondary school, high school, college or above), household income (⩽500, 501--1500, 1501--3000 or \>3000 yuan/month/person), current smoking (yes or no), current drinking (yes or no), exposure to toxic substances (yes or no), multivitamin supplement use during the past year (yes or no), history of chronic rhinitis (yes or no), physical activity (MET-h per day), dietary folate intake (*μ*g per day) and log-transformed daily energy intake (kcal per day). These variables were screened by the forward stepwise method and only significant variables were included in the final multivariable model, and criteria for entry and non-entry of covariates were *P*\<0.05 and *P*\>0.10, respectively. Linear trends across increasing quartiles were tested by assigning quartiles as continuous variables in the regression. We repeated our main analysis using unconditional logistic regression and found the results to be essentially the same ([Appendix](#app1){ref-type="app"}).

To determine whether the total choline intake-NPC relation was modified by potential risk factors for NPC, including folate intake (\<401.7 *vs* ⩾401.7 *μ*g per day), current drinking (yes *vs* no), current smoking (yes *vs* no), exposure to toxic substances (yes *vs* no) and chronic rhinitis history (yes *vs* no), we conducted a stratified analysis based on these factors. As these factors were not matched between NPC patients and control subjects, we used unconditional logistic regression adjusted for covariates rather than a conditional approach. Interactions were estimated via multiplicative interaction terms in the multivariate models.

Results
=======

Some key characteristics of the 600 case and control pairs (448 male pairs and 152 female pairs are shown in [Table 1](#tbl1){ref-type="table"}. The mean (±s.d.) age for both NPC patients upon diagnosis and control subjects upon recruitment was (47.4±9.0) years. NPC patients had a higher BMI than that of control subjects (*P*=0.002). NPC patients were more likely to have a history of chronic rhinitis (*P*\<0.001) and to report lower intake of total energy (*P*=0.029) and folate (*P*\<0.001). No significant difference was observed for current drinking, current smoking, exposure to toxic substances or physical activity.

The mean (±s.d.) energy-adjusted intake of betaine was 264.5 (±180.5) mg per day for NPC patients and 313.8 (±222.3) mg per day for control subjects and that of total choline as 184.4 (±66.0) mg per day for NPC patients and 202.7 (±75.0) mg per day for control subjects ([Table 1](#tbl1){ref-type="table"}). NPC patients reported lower intake of total choline, phosphatidylcholine, free choline, glycerophosphocholine, and phosphocholine and betaine (all *P* ⩽0.001) ([Table 1](#tbl1){ref-type="table"}). Phosphatidylcholine made the greatest contribution to the total choline intake (55.6% for NPC patients and 55.2% for control subjects), followed by free choline (24.0% for NPC patients and 24.5% for control subjects) ([Table 1](#tbl1){ref-type="table"}). Overall, eggs (26.9%) and Chinese flowering cabbage, mustard greens, collard greens and broccoli (17.1%) contributed \>10% to the total choline intake; spinach, amaranth and water spinach (79%) were the main sources of betaine ([Table 2](#tbl2){ref-type="table"}).

The five main choline-containing compounds were all significantly correlated (all *P*\<0.01), and Pearson\'s correlation coefficients ranged from 0.108 to 0.767 for cases, and from 0.158 to 0.732 for controls ([Table 3](#tbl3){ref-type="table"}).

Associations between choline and betaine intake and NPC risk are shown in [Table 4](#tbl4){ref-type="table"}. Both with and without adjustment for a number of lifestyle and dietary factors, a higher intake of total choline, betaine and total choline+betaine intake was associated with a significantly lower risk of NPC (*P-*trend \<0.001 for all). When the extreme quartiles of intake were compared, the adjusted OR (95% CI) was 0.42 (0.29, 0.61) for total choline intake, 0.50 (0.35, 0.72) for betaine intake, and 0.44 (0.30, 0.64) for betaine+total choline intake.

We also examined associations between the intake of the five main choline-containing compounds and NPC risk ([Table 5](#tbl5){ref-type="table"}). According to the multivariate analysis, NPC risk was inversely associated with the intake of choline from phosphatidylcholine (*P-*trend=0.004), free choline (*P-*trend \<0.001), glycerophosphocholine (*P-*trend=0.019) and phosphocholine (*P-*trend \<0.001), but not from sphingomyelin (*P-*trend=0.207). Compared with the lowest quartile, the adjusted OR (95% CI) of NPC risk for the highest quartile was 0.58 (0.40, 0.86) for phosphatidylcholine, 0.38 (0.26, 0.55) for free choline, 0.53 (0.36, 0.78) for glycerophosphocholine and 0.37 (0.26, 0.54) for phosphocholine.

Whether the potential risk factors modified the association between total choline and NPC risk is shown in [Table 6](#tbl6){ref-type="table"}. The association between total choline intake and NPC risk was stronger among patients without exposure to toxic substances than among patients with exposure (*P-*trend: \<0.001 *vs* 0.019; *P*-interaction: 0.013). In addition, we found the inverse association between total choline intake and NPC risk was only found among those without current alcohol intake (*P-*trend: \<0.001), but not among current drinkers (*P-*trend: 0.093). However, the *P-*values for the interaction were insignificant (*P-*interaction: 0.777). We also did stratification for eggs intake (\<291.0 *vs* ⩾291.0 *μ*g per day), because it was the major source of total choline, but no interaction was observed (*P-*interaction=0.829) (data no shown).

Discussion
==========

This hospital-based case--control study is, to the best of our knowledge, the first to examine and observe a significant inverse relationship between choline and betaine intakes and risk of NPC. Individual dietary sources of choline, that is, phosphatidylcholine, free choline, glycerophosphocholine, and phosphocholine, were also associated with NPC risk.

Recent epidemiological studies investigating the association between choline and betaine intake and various types of cancer, most of which were conducted in USA, have yielded conflicting findings. From a case--control study conducted in the same geographic area as our study, [@bib46] reported that intakes of choline and betaine were inversely related to the risk of breast cancer. Similar results were observed in a study by [@bib37], but no associations were found in others ([@bib8], [@bib9]; [@bib36], [@bib38]). Higher intakes of choline and betaine were associated with a lower risk of lung cancer, but not with the risk of renal cell cancer ([@bib7]), epithelial ovarian cancer ([@bib22]), colorectal cancer ([@bib26]) or oesophageal cancer ([@bib20]). One study showed that increased choline intake had a detrimental effect on the incidence of and survival from lethal-type prostate cancer ([@bib31]). Differences in types of cancers, study design, sample size, methods of measuring dietary nutrients and adjustment for covariates may account, at least in part, for the different findings across studies. In addition, comparing with other populations, Chinese usually consuming a lower level of dietary total choline (about 200 mg per day among Chinese *vs* about 300 mg per day among most of other populations), but a higher level of dietary betaine (about 310 mg per day among Chinese *vs* 49.8 to 190 mg per day among other populations), might also contribute to the inconsistencies ([@bib8], [@bib9], [@bib7]; [@bib36], [@bib38]; [@bib22]; [@bib31]; [@bib46]). Our results were consistent with the findings of [@bib46], showing that higher intakes of choline and betaine can reduce the risk of NPC.

Regarding specific types of choline, we found choline from phosphatidylcholine, free choline, glycerophosphocholine and phosphocholine to be related to a lower risk of NPC. However, [@bib46] reported that all five of the main dietary sources of choline have a protective effect on breast cancer risk. The lack of an association between sphingomyelin and lower risk is probably due to the relatively low levels (mean levels for sphingomyelin *vs* the other four sources (controls): 6.4 mg per day *vs* 15.3--116.2 mg per day). Thus, it might be more difficult to accurately measure sphingomyelin, which would lead to greater variation in the observed association.

In our study, choline was abundantly derived from eggs (26.9%) and Chinese flowering cabbage, mustard greens, collard greens and broccoli (17.1%), whereas the main sources of betaine were spinach, amaranth and water spinach (79%). Chinese flowering cabbage, mustard greens, collard greens, broccoli and spinach, amaranth, and water spinach are all dark green leafy vegetables, and increasing the intake of dark green vegetables was associated with a lower risk of NPC in our previous study ([@bib29]). This association is also supported by other studies ([@bib47]; [@bib1]; [@bib13]; [@bib41]). However, eggs were inconsistently not related or positively related with the risk of larynx or pharyngeal cancer ([@bib35]; [@bib2]), and the beneficial effect of choline derived from eggs is probably offset by the significantly high cholesterol content, which has been shown to increase cancer risk ([@bib23]).

Although the exact mechanisms by which high choline and betaine intakes protect against NPC risk are unclear, the association with carcinogenesis is biologically plausible. Overall, these two nutrients serve as methyl donors in one-carbon metabolism ([@bib24]). One-carbon metabolism affects the level of DNA methylation through a series of biochemical reactions involving in the transfer of methyl groups from one compound to another to generate the universal methyl donor S-adenosylmethionine ([@bib24]). Epigenetic variations in DNA, particularly CpG site methylation, have an important role in genome regulation ([@bib28]). Deficiency of methyl donors in one-carbon metabolism leading to disruption of DNA methylation and impaired DNA repair are thought to be the main underlying mechanism for carcinogenesis ([@bib12]). Animal models have shown that a diet deficient in methyl (for example, folate, choline or methionine) causes decreased tissue S-adenosylmethionine, global DNA hypomethylation, hepatic steatosis, cirrhosis and ultimate hepatic tumorigenesis in rodents ([@bib12]). Furthermore, the variation in genes involved in choline and betaine metabolism, such as the G774C polymorphism in phosphatidylethanolamine N-methyltransferase (PEMT, catalysing the methylation of phosphatidylethanolamine to form phosphatidylcholine) and the G432T polymorphism in choline dehydrogenase (CHDH, catalysing the oxidation of choline to betaine), have been associated with higher risk of breast cancer ([@bib38]), 742 GA polymorphism in betaine-homocysteine methyltransferase (BHMT, utilising betaine as the methyl donor to remethylate homocysteine to methionine) increased the risk of head and neck squamous cell carcinoma ([@bib11]).

We observed that exposure to toxic substances has a strong modifying effect on the association between choline intake and risk of NPC. The inverse association appeared to be particularly strong among those individuals without exposure to toxic substances, especially for the third quartile (OR for Q3 *vs* Q1: 0.35 *vs* 0.87, *P-*interaction=0.013). Toxic substances (for example, fumes, smoke and chemicals) are traditional risk factors for NPC, and exposure to such substances can significantly increase the risk of NPC ([@bib17]). Toxicity studies on vertebrates have shown that chemicals (for example, the widely used alkanolamines) can inhibit cellular choline uptake and cause choline deficiency ([@bib16]). Thus, we can hypothesise that toxic substances mitigate the protective effect of choline intake on NPC by affecting choline metabolism. However, the nonlinear trend for those never exposed to toxic substances needs further study for elucidation of the underlying mechanisms of this finding.

The strengths of the study are the relatively large number of subjects, the good matching by age, sex and residence between the NPC patients and the control subjects, the use of a validated and reproducible FFQ ([@bib45]; [@bib46]), assessment of portion size by means of visual aids, the trained interviewers and the equal number of patient and control interviews conducted by the individual investigators.

The results of this study should be interpreted in light of several limitations. First, reverse causality could not be fully excluded in a case--control study, because the diet data were collected after the diagnoses of NPC. We minimised this possibility by including only incident cases and by meticulously excluding individuals with essential changes in their diet habits in recent 5 years. Of course, cohort study design is an ideal way to overcome this defect. Up to date, few prospective cohort studies have focused on NPC and all of them had a small number of NPC cases (all \<200 cases) due to a low incidence ([@bib6]; [@bib27]; [@bib15]; [@bib19]). Second, inaccurate recall of habitual diet is unavoidable in retrospective studies, but differential report between cases and controls was unlikely to be present in this study as there was little public awareness about dietary choline/betaine and its potential to cancer risk. Third, NPC patients and control subjects were recruited from two different hospital centres, which might influence the representations. However, both centres were the top ranking specialised hospitals in the South China with comparable reputation and coverage area. The major demographic characteristics (for example, age, sex) of our case patients were comparable to those in a population-based NPC epidemiological survey ([@bib21]). Fourth, the use of hospital patients as control subjects is a potential limitation because their dietary habits may differ from those of the general healthy population in the same catchment area. However, we included only control subjects with conditions (for example, ocular fundus disease, ocular trauma, glaucoma and ophthalmic plastic surgery) not related to long-term dietary modifications. Further, the use of hospital control subjects tends to reduce differential report on diet ([@bib3]). Fifth, the reliability of estimated choline and betaine intake should be considered. Although the databases from the USA allowed us to quantify a broad range of choline and betaine intakes, the nutrient content of foods may vary by geographic origin, growing season, different cultivars, agricultural methods and processing ([@bib5]). This information was not available to us, and some measurement error is inevitable, but the results seem to be not significantly affected because the choline and betaine contents of the main source foods (for example, vegetables) are similar, whether these foods are cooked or raw ([@bib43], [@bib44]). In addition, our analysis was based on a single measurement of dietary intake; thus, any misclassification could skew any true association ([@bib32]). Sixth, although we adjusted a wide range of dietary and lifestyle factors known to potentially affect cancer risk and the multivariate analysis yielded results similar to those of crude analysis, we could not rule out the possibility of bias from residual confounding. Seventh, high choline and betaine intake may be representative of a healthy lifestyle in general; however, a significant association was observed with betaine but not with all types of choline, thus the possibility of residual confounding by a healthy lifestyle may have been minimised. Eighth, high intakes of dark green leafy vegetables are a major source of these exposures. We could not rule out the influence of those co-existing bioactive compounds that might prevent nasopharyngeal oncogenesis ([@bib18]; [@bib30]). Moreover, we did not research on the genetic susceptibility, such as polymorphisms in PEMT, CHDH and BHMT involving in choline or betaine metabolism.

In conclusion, our study supports a protective role of choline and betaine intakes against the development of NPC. Given the findings obtained in similar populations for breast cancer ([@bib46]), these data suggest the importance of choline and betaine intake in the process of carcinogenesis. Considering the pitfalls of hospital-based case--control studies, our findings need confirmation by large well-designed studies, especially large-scale cohort studies.
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###### Comparison of key characteristics between nasopharyngeal carcinoma cases and controls[a](#t1-fn1){ref-type="fn"}

  **Characteristics**                                                   **Cases (*n*=600)**   **Controls (*n*=600)**   ***P*****-value**
  --------------------------------------------------------------------- --------------------- ------------------------ -------------------
  Age, years                                                            47.4±9.0              47.4±9.0                 0.992
  Body mass index, kg m^−2^                                             23.2±3.1              22.7±2.8                 0.002
  Current drinking, *n* (%)[b](#t1-fn2){ref-type="fn"}                  132 (22.0)            121 (20.2)               0.489
  Current smoking, *n* (%)[c](#t1-fn3){ref-type="fn"}                   294 (49.0)            277 (46.2)               0.343
  Exposure to toxic substances, *n* (%)[d](#t1-fn4){ref-type="fn"}      274 (45.7)            269 (44.8)               0.814
  Chronic rhinitis history, *n* (%)                                     164 (27.3)            108 (18.0)               \<0.001
  Physical activity, MET•h per day[e](#t1-fn5){ref-type="fn"}           38.4±9.4              39.5±11.8                0.073
  Total energy intake, kcal per day                                     1873±600              1953±642                 0.029
  Folate intake, *μ*g per day[f](#t1-fn6){ref-type="fn"}                396.2±87.3            419.6±96.3               \<0.001
  Total choline intake, mg per day[f](#t1-fn6){ref-type="fn"}           184.4±66.0            202.7±75.0               \<0.001
  Phosphatidylcholine intake, mg per day[f](#t1-fn6){ref-type="fn"}     105.8±50.5            116.2±59.0               0.001
  Free choline intake, mg per day[f](#t1-fn6){ref-type="fn"}            42.2±13.7             46.9±14.7                \<0.001
  Glycerophosphocholine intake, mg per day[f](#t1-fn6){ref-type="fn"}   16.9±5.5              18.1±7.0                 0.001
  Phosphocholine intake, mg per day[f](#t1-fn6){ref-type="fn"}          13.1±7.2              15.3±7.6                 \<0.001
  Sphingomyelin intake, mg per day[f](#t1-fn6){ref-type="fn"}           6.5±4.4               6.4±4.6                  0.915
  Betaine intake, mg per day[f](#t1-fn6){ref-type="fn"}                 264.5±180.5           313.8±222.3              \<0.001

Abbreviation: MET=metabolic equivalent case.

Continous values are means±s.d.

Current drinking was defined as having had alcohol drink at least once daily for at least six consecutive months.

Current smoking was defined as having smoked at least one cigarette daily for at least six consecutive months.

Exposure to potential toxic substances or detrimental environment included ever exposuring to one of the following factors over 1 year: heat, organic solvents, pesticides, heavy metals, smoke from burning incense, anti-mosquito coils, new furniture or decoration and radiation.

Physical activities included daily occupational, leisure-time and household-chores, evaluated by metabolic equivalent (MET) hours per day.

Energy-adjusted intake.

###### Top five contributors of food sources (percentage contribution to total intake) of betaine, total choline and choline-containing compounds among control subjects

  **Food source**                                                          **Proportion (%)**
  ------------------------------------------------------------------------ --------------------
  **Total choline**                                                        
  Eggs                                                                     26.9
  Chinese flowering cabbage, mustard greens, collard greens and broccoli   17.1
  Poultry with skin                                                        8.2
  Rice                                                                     5.7
  Nuts                                                                     4.5
  **Phosphatidylcholine (55.2% of total choline)**                         
  Eggs                                                                     44.3
  Chinese flowering cabbage, mustard greens, collard greens and broccoli   15.5
  Poultry with skin                                                        9.5
  Spinach, amaranth, and water spinach                                     4.9
  Nuts                                                                     4.8
  **Free choline (24.5% of total choline)**                                
  Chinese flowering cabbage, mustard greens, collard greens and broccoli   16.0
  Pakchoi and lettuce                                                      12.9
  Rice                                                                     8.8
  Chinese cabbage, white flower vegetables, and celery                     7.4
  Nuts                                                                     6.7
  **Glycerophosphocholine (9.7% of total choline)**                        
  Rice                                                                     29.5
  Whole milk                                                               12.4
  Porridge                                                                 10.1
  Chinese flowering cabbage, mustard greens, collard greens and broccoli   6.3
  Banana                                                                   6.1
  **Phosphocholine (7.7% of total choline)**                               
  Chinese flowering cabbage, mustard greens, collard greens and broccoli   51.4
  Pakchoi and lettuce                                                      9.5
  Poultry with skin                                                        5.5
  Whole milk                                                               3.5
  Root vegetables                                                          3.1
  **Sphingomyelin (3.0% of total choline)**                                
  Poultry with skin                                                        43.8
  Eggs                                                                     35.4
  Skinless poultry                                                         10.5
  Whole milk                                                               2.9
  Processed meat                                                           2.5
  **Betaine**                                                              
  Spinach, amaranth and water spinach                                      79.0
  Noodles                                                                  9.1
  Steamed buns                                                             4.1
  Whole-wheat bread                                                        3.0
  Root vegetables                                                          1.5

###### Pearson\'s correlation coefficients for cases and controls among five main choline-containing compounds

                          **Free choline**   **Glycerophosphocholine**   **Phosphocholine**   **Sphingomyelin**                           
  ----------------------- ------------------ --------------------------- -------------------- ------------------- ------- ------- ------- -------
  Phosphatidylcholine     0.407              0.356                       0.140                0.158               0.412   0.346   0.660   0.711
  Free choline                                                           0.468                0.485               0.767   0.732   0.108   0.172
  Glycerophosphocholine                                                                                           0.334   0.354   0.115   0.208
  Phosphocholine                                                                                                                  0.164   0.183

All *P*\<0.01.

###### Risk of nasopharyngeal carcinoma for quartiles of dietary choline and betaine intake in Guangzhou, China

                                                        **Cases (*****n*****=600)**               **Controls (*****n*****=600)**                  **Without adjusted**                  **Multivariate adjusted**[a](#t4-fn2){ref-type="fn"}                            
  ----------------------------------------- ---------------------------------------------------- -------------------------------- ---------------------------------------------------- ------------------------------------------------------ ------------------------- -------------------------
                                             **Median (mg per day)**[b](#t4-fn3){ref-type="fn"}              ***n***               **Median (mg per day)**[b](#t4-fn3){ref-type="fn"}                         ***n***                          **Odds ratio (95% CI)**   **Odds ratio (95% CI)**
  **Quartile of total choline**                                                                                                                                                                                                                                         
  Q1                                                                125                                        204                                        121                                                   150                                     1.00                      1.00
  Q2                                                                170                                        180                                        173                                                   150                               0.86 (0.63--1.17)         0.80 (0.57--1.11)
  Q3                                                                218                                        116                                        216                                                   150                               0.53 (0.38--0.75)         0.45 (0.31--0.66)
  Q4                                                                285                                        100                                        286                                                   150                               0.47 (0.33--0.66)         0.42 (0.29--0.61)
  *P*-trend                                                                                                                                                                                                                                            \<0.001                   \<0.001
  **Quartile of betaine**                                                                                                                                                                                                                                               
  Q1                                                                112                                        208                                        101                                                   150                                     1.00                      1.00
  Q2                                                                211                                        158                                        206                                                   150                               0.77 (0.57--1.04)         0.69 (0.50--0.96)
  Q3                                                                327                                        132                                        329                                                   150                               0.64 (0.46--0.87)         0.56 (0.40--0.80)
  Q4                                                                539                                        102                                        548                                                   150                               0.50 (0.36--0.69)         0.50 (0.35--0.72)
  *P*-trend                                                                                                                                                                                                                                            \<0.001                   \<0.001
  **Quartile of total choline + betaine**                                                                                                                                                                                                                               
  Q1                                                                285                                        222                                        278                                                   150                                     1.00                      1.00
  Q2                                                                411                                        155                                        407                                                   150                               0.69 (0.51--0.93)         0.63 (0.45--0.89)
  Q3                                                                530                                        127                                        558                                                   150                               0.55 (0.40--0.76)         0.48 (0.34--0.69)
  Q4                                                                761                                         96                                        779                                                   150                               0.42 (0.30--0.59)         0.44 (0.30--0.64)
  *P*-trend                                                                                                                                                                                                                                            \<0.001                   \<0.001

Abbreviation: CI=confidence interval.

Crude and adjusted ORs (95% CI) from conditional logistic model. Covariates includes age, BMI, occupation, marital status, educational level, household income, current smoking, current drinking, exposure to potential toxic substances, multivitamin supplement, chronic rhinitis history, physical activity, dietary folate intake and daily energy intake (log-transformed).

Median percentage of total energy in cases and controls.

###### Risk of nasopharyngeal carcinoma for quartiles of five main choline-containing compound intakes in Guangzhou, China

                                          **Cases (*****n*****=600)**   **Controls (*****n*****=600)**   **Without adjusted**   **Multivariate adjusted**[a](#t5-fn1){ref-type="fn"}                       
  --------------------------------------- ----------------------------- -------------------------------- ---------------------- ------------------------------------------------------ ------------------- -------------------
  **Quartile of phosphatidylcholine**                                                                                                                                                                      
  Q1                                      61.5                          191                              58.6                   150                                                    1.00                1.00
  Q2                                      91.8                          163                              93.0                   150                                                    0.85 (0.62--1.16)   0.83 (0.59--1.16)
  Q3                                      120.0                         132                              122.6                  150                                                    0.67 (0.48--0.93)   0.66 (0.45--0.95)
  Q4                                      175.6                         114                              179.8                  150                                                    0.56 (0.40--0.79)   0.58 (0.40--0.86)
  *P*-trend                                                                                                                                                                            \<0.001             0.004
  **Quartile of free choline**                                                                                                                                                                             
  Q1                                      31.1                          233                              31.1                   150                                                    1.00                1.00
  Q2                                      40.6                          152                              40.6                   150                                                    0.64 (0.47--0.88)   0.61 (0.43--0.84)
  Q3                                      49.3                          118                              49.7                   150                                                    0.49 (0.35--0.68)   0.41 (0.29--0.59)
  Q4                                      61.3                          97                               63.4                   150                                                    0.41 (0.29--0.58)   0.38 (0.26--0.55)
  *P*-trend                                                                                                                                                                            \<0.001             \<0.001
  **Quartile of glycerophosphocholine**                                                                                                                                                                    
  Q1                                      11.8                          165                              11.8                   150                                                    1.00                1.00
  Q2                                      14.8                          154                              14.9                   150                                                    0.94 (0.68--1.28)   0.96 (0.68--1.35)
  Q3                                      18.1                          181                              18.2                   150                                                    1.09 (0.80--1.49)   1.16 (0.82--1.65)
  Q4                                      25.3                          100                              25.4                   150                                                    0.60 (0.43--0.85)   0.53 (0.36--0.78)
  *P*-trend                                                                                                                                                                            0.026               0.019
  **Quartile of phosphocholine**                                                                                                                                                                           
  Q1                                      7.5                           234                              7.5                    150                                                    1.00                1.00
  Q2                                      11.6                          164                              12.1                   150                                                    0.69 (0.50--0.95)   0.60 (0.42--0.86)
  Q3                                      16.1                          100                              16.5                   150                                                    0.40 (0.28--0.57)   0.33 (0.22--0.48)
  Q4                                      23.5                          102                              23.7                   150                                                    0.43 (0.31--0.60)   0.37 (0.26--0.54)
  *P*-trend                                                                                                                                                                            \<0.001             \<0.001
  **Quartile of sphingomyelin**                                                                                                                                                                            
  Q1                                      2.27                          141                              1.86                   150                                                    1.00                1.00
  Q2                                      4.54                          167                              4.36                   150                                                    1.19 (0.86--1.65)   1.08 (0.76--1.55)
  Q3                                      7.01                          165                              6.86                   150                                                    1.17 (0.85--1.61)   1.02 (0.72--1.45)
  Q4                                      12.10                         127                              11.35                  150                                                    0.88 (0.63--1.25)   0.79 (0.54--1.15)
  *P*-trend                                                                                                                                                                            0.545               0.207

Abbreviation: CI=confidence interval.

Adjusted ORs (95% CI) from conditional logistic model. Covariates adjusted see [Table 4](#tbl4){ref-type="table"}.

Median percentage of total energy in cases and controls.

###### Risk of nasopharyngeal carcinoma for quartiles of total choline intake by risk factors and eggs intake in Guangzhou, China[a](#t6-fn2){ref-type="fn"}

  **Quartile of total choline**    **Odds ratio (95% CI)**   **Odds ratio (95% CI)**
  ------------------------------- ------------------------- -------------------------
  Folate intake                     \<401.7 *μ*g per day       ⩾401.7 *μ*g per day
  Q1                                        1.00                      1.00
  Q2                                  0.73 (0.48--1.10)         1.07 (0.63--1.81)
  Q3                                  0.46 (0.28--0.76)         0.62 (0.37--1.04)
  Q4                                  0.41 (0.23--0.73)         0.57 (0.34--0.96)
  *P*-trend                                \<0.001                    0.005
  *P*-interaction                           0.420           
  Current smoking                            Yes                       No
  Q1                                        1.00                      1.00
  Q2                                  0.99 (0.56--1.76)         0.75 (0.41--1.37)
  Q3                                  0.42 (0.22--0.81)         0.40 (0.21--0.79)
  Q4                                  0.35 (0.18--0.68)         0.39 (0.20--0.78)
  *P*-trend                                 0.006                     0.028
  *P*-interaction                           0.795           
  Current drinking                           Yes                       No
  Q1                                        1.00                      1.00
  Q2                                  1.49 (0.70--3.18)         0.71 (0.50--1.01)
  Q3                                  0.66 (0.30--1.45)         0.48 (0.33--0.72)
  Q4                                  0.60 (0.27--1.34)         0.44 (0.29--0.67)
  *P*-trend                                 0.093                    \<0.001
  *P*-interaction                           0.777           
  Exposure to toxic substances               Yes                       No
  Q1                                        1.00                      1.00
  Q2                                  0.98 (0.62--1.54)         0.72 (0.46--1.12)
  Q3                                  0.87 (0.54--1.42)         0.35 (0.22--0.57)
  Q4                                  0.50 (0.30--0.86)         0.46 (0.28--0.76)
  *P*-trend                                 0.019                    \<0.001
  *P*-interaction                           0.013           
  Chronic rhinitis history                   Yes                       No
  Q1                                        1.00                      1.00
  Q2                                  0.60 (0.30--1.21)         0.94 (0.66--1.35)
  Q3                                  0.54 (0.25--1.19)         0.51 (0.35--0.76)
  Q4                                  0.29 (0.13--0.65)         0.55 (0.36--0.84)
  *P*-trend                                 0.003                    \<0.001
  *P*-interaction                           0.896           

Abbreviation: CI=confidence interval.

Adjusted ORs (95% CI) from unconditional logistic model. Covariates adjusted: see [Table 4](#tbl4){ref-type="table"}.

###### Comparison of results of matched and unmatched analysesa[a](#ta1-fn1){ref-type="fn"}

                            **Matched**         **Unmatched**                       
  ------------------------- ------------------- --------------- ------------------- ---------
  Total choline             0.42 (0.29, 0.61)   \<0.001         0.49 (0.34, 0.70)   \<0.001
  Phosphatidylcholine       0.58 (0.40, 0.86)   0.004           0.62 (0.43, 0.88)   0.003
  Free choline              0.38 (0.26, 0.55)   \<0.001         0.45 (0.31, 0.65)   \<0.001
  Glycerophosphocholine     0.53 (0.36, 0.78)   0.019           0.61 (0.43, 0.85)   0.026
  Phosphocholine            0.37 (0.26, 0.54)   \<0.001         0.45 (0.32, 0.63)   \<0.001
  Sphingomyelin             0.79 (0.54, 1.15)   0.207           0.81 (0.57, 1.14)   0.231
  Betaine                   0.50 (0.35, 0.72)   \<0.001         0.49 (0.35, 0.69)   \<0.001
  Betaine + total choline   0.44 (0.30, 0.64)   \<0.001         0.42 (0.30, 0.60)   \<0.001

Addjusted odds ratios (95% CI) were Quartile 4 (the highest) *vs* Quartile 1 from unconditional logistic model. Covariates adjusted: see [Table 4](#tbl4){ref-type="table"}.

[^1]: These authors contributed equally to this work.
